Abstract
This cohort study examines the outcomes of a program providing monoclonal antibody treatments to COVID-19–positive patients in their homes.
MeSH terms
-
Antibodies, Monoclonal / therapeutic use*
-
COVID-19 / therapy*
-
Cohort Studies
-
Female
-
Home Care Services / statistics & numerical data*
-
Humans
-
Immunologic Factors / therapeutic use*
-
Male
-
Michigan
-
Middle Aged
-
SARS-CoV-2 / immunology
Substances
-
Antibodies, Monoclonal
-
Immunologic Factors